Skip to main content
Signal8

ROBINS HARLAN S

SEC insider (Form 3/4/5 filer). CIK 0001780851. Chief Scientific Officer at Adaptive Biotechnologies Corp (ADPT). 27 reported Form 4/5 transactions since Sep 2024; latest on Jul 21, 2026. Located in SEATTLE, WA.

Companies ROBINS HARLAN S has filed insider reports for

  • Adaptive Biotechnologies Corp (ADPT): Officer, Chief Scientific Officer
ROBINS HARLAN S profile photo

ROBINS HARLAN S

CIK: 0001780851

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)21 (77.8%)

Position reduction

Option Exercises (M)3 (11.1%)

Derivative conversions

Awards (A)3 (11.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Adaptive Biotechnologies Corp logo
ADPT

Adaptive Biotechnologies Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (27 total)

  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jul 21, 2026
    Sale
    Direct
    213.7K shares at avg. $22.12$4.7M
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jul 21, 2026
    Exercise
    Direct
    284.8K shares at avg. $6.55$1.9M
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jul 21, 2026
    Sale
    Direct
    278.7K shares at avg. $21.72$6.1M
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jul 2, 2026
    Sale
    Direct
    146.9K shares at avg. $22.45$3.3M
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jul 2, 2026
    Sale
    Direct
    239.4K shares at avg. $21.74$5.2M
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jun 16, 2026
    Sale
    Direct
    6.2K shares at avg. $18.01$111K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jun 15, 2026
    Sale
    Direct
    100K shares at avg. $17.37$1.7M
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Apr 8, 2026
    Sale
    Direct
    10K shares at avg. $14.85$149K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Mar 11, 2026
    Sale
    Direct
    140.7K shares at avg. $13.17$1.9M
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Mar 11, 2026
    Sale
    Direct
    329.6K shares at avg. $13.17$4.3M

1-10 of 27